tranexamic acid has been researched along with Hemorrhage, Uterine in 33 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although intravascular thrombi and infarct-type necrosis have been reported in leiomyomas following tranexamic acid therapy, intratumoral vasculopathy resembling acute atherosis has not been reported to date in patients without exposure to gonadotropin receptor agonist." | 7.85 | Intratumoral Vasculopathy in Leiomyoma Treated With Tranexamic Acid. ( Krigman, HR; Kudose, S, 2017) |
| "This study investigated the efficacy of GnRH agonists concomitantly with transient aromatase inhibitor and tranexamic acid to treat women with uterine arteriovenous malformations (AVMs) associated with abnormal uterine bleeding (AUB) to preserve fertility and determine reproductive outcome." | 3.91 | Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid. ( Abu-Rafea, B; Machado, M; Oraif, A; Vilos, AG; Vilos, GA, 2019) |
| "Although intravascular thrombi and infarct-type necrosis have been reported in leiomyomas following tranexamic acid therapy, intratumoral vasculopathy resembling acute atherosis has not been reported to date in patients without exposure to gonadotropin receptor agonist." | 3.85 | Intratumoral Vasculopathy in Leiomyoma Treated With Tranexamic Acid. ( Krigman, HR; Kudose, S, 2017) |
| " A rapid recourse to prostaglandins (sulprostone in France) may reverse uterine atony." | 3.83 | Major obstetric hemorrhage. ( Le Gouez, A; Mercier, FJ, 2016) |
| " We present a case of postmenopausal bleeding, because of chronic DIC, which resulted from aortic aneurysm and was managed with replacement blood products and tranexamic acid." | 3.72 | Postmenopausal bleeding due to chronic DIC. ( Bollapragada, SS; Garg, M; McFarlane, T, 2004) |
| "Tranexamic acid is a synthetic lysine derivative with antifibrinolytic activity used in other surgical disciplines to reduce blood loss during surgery." | 2.94 | Intraoperative tranexamic acid to decrease blood loss during myomectomy: a randomized, double-blind, placebo-controlled trial. ( Maasen, MS; Marfori, CQ; Moawad, G; Opoku-Anane, J; Robinson, JK; Vargas, MV, 2020) |
| "Uterine fibroids are the commonest tumour of the female genital tract; about one third are symptomatic and require management." | 2.90 | Adjunctive use of tranexamic acid to tourniquet in reducing haemorrhage during abdominal myomectomy - A randomized controlled trial. ( Abdul, IF; Adesina, KT; Amadu, MB; Olarinoye, AO; Omokanye, LO, 2019) |
| "Tranexamic acid was more effective than placebo in short-term treatment of irregular uterine bleeding/spotting associated with DMPA use." | 2.74 | The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use. ( Senthong, AJ; Taneepanichskul, S, 2009) |
| "Women with advanced cancer of the cervix often need palliation for distressing symptoms, such as vaginal bleeding." | 2.61 | Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. ( Eke, AC; Eleje, GU; Eleje, LI; Igberase, GO; Igwegbe, AO, 2019) |
| "The most common form of BDs is von Willebrand Disease, reflecting 13% of adolescents with AUB." | 2.58 | Abnormal Uterine Bleeding including coagulopathies and other menstrual disorders. ( Deligeoroglou, E; Karountzos, V, 2018) |
| "Abnormal uterine bleeding is one of the most common reasons for outpatient gynecologic visits." | 2.58 | Abnormal Uterine Bleeding: Treatment Options. ( Oberman, E; Rodriguez-Triana, V, 2018) |
| " The effectiveness of treatment methods and the optimal dosage of misoprostol are research priorities." | 2.53 | Preventing deaths due to haemorrhage. ( Hofmeyr, GJ; Qureshi, Z, 2016) |
| "Women with advanced cancer of the cervix often need palliation for distressing symptoms, such as vaginal bleeding." | 2.52 | Palliative interventions for controlling vaginal bleeding in advanced cervical cancer. ( Eke, AC; Eleje, GU; Eleje, LI; Igberase, GO; Igwegbe, AO, 2015) |
| "Dysfunctional uterine bleeding is defined as heavy menstrual uterine bleeding not due to any recognisable cause and is therefore a diagnosis of exclusion." | 2.42 | Dysfunctional uterine bleeding. ( Farrell, E, 2004) |
| "Abnormal uterine bleeding is a common gynaecological problem that traditionally has been treated with hysterectomy." | 2.41 | Alternatives to hysterectomy for the treatment of excessive uterine bleeding. ( Liu, J; Robins, JC, 2000) |
| "Uterine leiomyomas (fibroids) are the most common solid and symptomatic neoplasm in women." | 1.62 | Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. ( , 2021) |
| "Cervical cancer is the commonest cancer affecting women in Malawi, which has the highest rate of this disease in the world." | 1.42 | A review of patients with advanced cervical cancer presenting to palliative care services at Queen Elizabeth Central Hospital in Blantyre, Malawi. ( Bates, MJ; Mijoya, A, 2015) |
| "Severe vaginal bleeding can be the result of cervical arteriovenous malformation, and GnRH agonist may be used for treatment." | 1.32 | A life-threatening event: uterine cervical arteriovenous malformation. ( Amit, A; Deutsch, M; Kerner, H; Lowenstein, L; Solt, I, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.15) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 16 (48.48) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul, IF | 1 |
| Amadu, MB | 1 |
| Adesina, KT | 1 |
| Olarinoye, AO | 1 |
| Omokanye, LO | 1 |
| Opoku-Anane, J | 1 |
| Vargas, MV | 1 |
| Marfori, CQ | 1 |
| Moawad, G | 1 |
| Maasen, MS | 1 |
| Robinson, JK | 1 |
| Deligeoroglou, E | 1 |
| Karountzos, V | 1 |
| Oberman, E | 1 |
| Rodriguez-Triana, V | 1 |
| Vilos, AG | 1 |
| Oraif, A | 1 |
| Machado, M | 1 |
| Abu-Rafea, B | 1 |
| Vilos, GA | 1 |
| Eleje, GU | 2 |
| Eke, AC | 2 |
| Igberase, GO | 2 |
| Igwegbe, AO | 2 |
| Eleje, LI | 2 |
| Bistervels, IM | 1 |
| Scheres, LJJ | 1 |
| Hamulyák, EN | 1 |
| Middeldorp, S | 1 |
| Friedlander, E | 1 |
| Kaneshiro, B | 1 |
| Bates, MJ | 1 |
| Mijoya, A | 1 |
| Hofmeyr, GJ | 1 |
| Qureshi, Z | 1 |
| Le Gouez, A | 1 |
| Mercier, FJ | 1 |
| Kudose, S | 1 |
| Krigman, HR | 1 |
| Wiseman, DM | 1 |
| Meidler, R | 1 |
| Lyahovetsky, Y | 1 |
| Kurman, E | 1 |
| Horn, S | 1 |
| Nur, I | 1 |
| Sekhavat, L | 1 |
| Tabatabaii, A | 1 |
| Dalili, M | 1 |
| Farajkhoda, T | 1 |
| Tafti, AD | 1 |
| Senthong, AJ | 1 |
| Taneepanichskul, S | 1 |
| Boama, V | 1 |
| Haynes, S | 1 |
| Movafegh, A | 1 |
| Eslamian, L | 1 |
| Dorabadi, A | 1 |
| Martín-Salces, M | 1 |
| Jiménez-Yuste, V | 1 |
| Álvarez-Román, MT | 1 |
| Rivas-Pollmar, I | 1 |
| Rodríguez de la Rúa, A | 1 |
| Sajdak, S | 1 |
| Moszynski, R | 1 |
| Opala, T | 1 |
| Huang, Z | 1 |
| Fang, A | 1 |
| Dai, Z | 1 |
| Bollapragada, SS | 1 |
| Garg, M | 1 |
| McFarlane, T | 1 |
| Lowenstein, L | 1 |
| Solt, I | 1 |
| Deutsch, M | 1 |
| Kerner, H | 1 |
| Amit, A | 1 |
| Farrell, E | 1 |
| Fernandez, H | 1 |
| Gervaise, A | 1 |
| Lundvall, F | 1 |
| Nielsen, NC | 1 |
| Agnelli, G | 1 |
| Gresele, P | 1 |
| De Cunto, M | 1 |
| Gallai, V | 1 |
| Nenci, GG | 1 |
| Valsecchi, A | 2 |
| Robins, JC | 1 |
| Liu, J | 1 |
| Nilsson, IM | 1 |
| Cappelletti, M | 1 |
| Sapire, KE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Intravenous Tranexamic Acid Plus Intramyometrial Desmopressin on Blood Loss During Laparoscopic Myomectomy: Randomized, Double-blind, Placebo-controlled Trial[NCT05517590] | 100 participants (Anticipated) | Interventional | 2022-09-01 | Recruiting | |||
| Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial[NCT02739815] | Phase 4 | 200 participants (Actual) | Interventional | 2016-04-30 | Completed | ||
| Tranexamic Acid Versus Novel Uterine Cooling Technique in Reducing Blood Loss and Incidence of Postpartum Hemorrhage at Caesarean Section[NCT02780245] | Phase 4 | 100 participants (Actual) | Interventional | 2016-06-30 | Completed | ||
| A Novel Technique Of Uterine Cooling During Repeated Cesarean Section For Reducing Blood Loss[NCT03793153] | 99 participants (Actual) | Interventional | 2018-12-19 | Completed | |||
| Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial[NCT01600599] | 40 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for tranexamic acid and Hemorrhage, Uterine
| Article | Year |
|---|---|
Abnormal Uterine Bleeding including coagulopathies and other menstrual disorders.
Topics: Adolescent; Antifibrinolytic Agents; Contraceptives, Oral, Combined; Female; Humans; Menorrhagia; Me | 2018 |
Abnormal Uterine Bleeding: Treatment Options.
Topics: Antifibrinolytic Agents; Contraceptives, Oral; Female; Gynecologic Surgical Procedures; Gynecologica | 2018 |
Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
Topics: Antifibrinolytic Agents; Female; Humans; Palliative Care; Tampons, Surgical; Tranexamic Acid; Uterin | 2019 |
Sex matters: Practice 5P's when treating young women with venous thromboembolism.
Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low- | 2019 |
Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
Topics: Antifibrinolytic Agents; Female; Humans; Palliative Care; Tampons, Surgical; Tranexamic Acid; Uterin | 2015 |
Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraception; Doxycycline; | 2015 |
Preventing deaths due to haemorrhage.
Topics: Abruptio Placentae; Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Crystalloid Soluti | 2016 |
Dysfunctional uterine bleeding.
Topics: Antifibrinolytic Agents; Diagnosis, Differential; Female; Gynecologic Surgical Procedures; Humans; I | 2004 |
[Dysfunctionnal uterin bleedings].
Topics: Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Pregnancy; Premenopause; Tranexamic Acid; | 2007 |
Alternatives to hysterectomy for the treatment of excessive uterine bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Catheter Ablation; Contraceptives, | 2000 |
Local fibrinolysis as a mechanism for haemorrhage.
Topics: Aminocaproates; Endometrium; Epistaxis; Female; Fibrinolysis; Gastric Juice; Gastrointestinal Hemorr | 1975 |
7 trials available for tranexamic acid and Hemorrhage, Uterine
| Article | Year |
|---|---|
Adjunctive use of tranexamic acid to tourniquet in reducing haemorrhage during abdominal myomectomy - A randomized controlled trial.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Female; Humans; Leiomyoma | 2019 |
Intraoperative tranexamic acid to decrease blood loss during myomectomy: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Female; Humans; Injection | 2020 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
Efficacy of tranexamic acid in reducing blood loss after cesarean section.
Topics: Adult; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Monitoring, Physiologic; Placebos; | 2009 |
The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use.
Topics: Adult; Antifibrinolytic Agents; Contraceptive Agents, Female; Double-Blind Method; Endometrium; Fema | 2009 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.
Topics: Adult; Antifibrinolytic Agents; Blood Loss, Surgical; Cesarean Section; Double-Blind Method; Female; | 2011 |
The hemostatic effect of tranexamic acid in conisatio colli uteri.
Topics: Adult; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Dilatation and Curettage; Double-Blind | 1984 |
A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments.
Topics: Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Injections; Medroxyprogesterone; | 1991 |
15 other studies available for tranexamic acid and Hemorrhage, Uterine
| Article | Year |
|---|---|
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Topics: Antifibrinolytic Agents; Contraceptive Agents, Hormonal; Endometrial Ablation Techniques; Ethinyl Es | 2021 |
Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
Topics: Abortion, Spontaneous; Adult; Antifibrinolytic Agents; Aromatase Inhibitors; Arteriovenous Fistula; | 2019 |
A review of patients with advanced cervical cancer presenting to palliative care services at Queen Elizabeth Central Hospital in Blantyre, Malawi.
Topics: Adult; Age Distribution; Anti-HIV Agents; Antifibrinolytic Agents; Female; HIV Infections; Humans; M | 2015 |
Major obstetric hemorrhage.
Topics: Blood Component Transfusion; Combined Modality Therapy; Dinoprostone; Factor VIIa; Female; Fibrinoge | 2016 |
Intratumoral Vasculopathy in Leiomyoma Treated With Tranexamic Acid.
Topics: Female; Humans; Hysterectomy; Leiomyoma; Menorrhagia; Middle Aged; Necrosis; Telangiectasia, Heredit | 2017 |
Evaluation of a fibrin preparation containing tranexamic acid (Adhexil) in a rabbit uterine horn model of adhesions with and without bleeding and in a model with two surgical loci.
Topics: Animals; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Female; Fibrin; He | 2010 |
Conservative management of a haemorrhagic adnexal cyst in a patient with Type 3 von Willebrand Disease.
Topics: Abdominal Pain; Adult; Antifibrinolytic Agents; Blood Component Transfusion; Coagulants; Factor VIII | 2011 |
Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Factor VIII; Female; Humans; In | 2012 |
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Topics: Adenocarcinoma; Administration, Intravaginal; Adult; Aged; Endometrial Neoplasms; Ethamsylate; Facto | 2002 |
Decreasing bleeding effect of transamin on the induced abortion.
Topics: Abortion, Induced; Female; Humans; Pregnancy; Tranexamic Acid; Uterine Hemorrhage | 2002 |
Postmenopausal bleeding due to chronic DIC.
Topics: Aged; Aortic Aneurysm; Blood Transfusion; Chronic Disease; Disseminated Intravascular Coagulation; F | 2004 |
A life-threatening event: uterine cervical arteriovenous malformation.
Topics: Adult; Antifibrinolytic Agents; Arteriovenous Malformations; Brachytherapy; Cervix Uteri; Embolizati | 2004 |
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report.
Topics: Adult; Carotid Artery Thrombosis; Carotid Artery, Internal; Cyclohexanecarboxylic Acids; Female; Hum | 1982 |
[Further notes on the topical use of tranexamic acid in the treatment of gynecological hemorrhage].
Topics: Adolescent; Adult; Aged; Cyclohexanecarboxylic Acids; Female; Hemorrhage; Humans; Metrorrhagia; Midd | 1980 |
[Possibilities of the use of an inhibitor of hemolysis (AMCHA), by rectal and vaginal administration, for gynecological hemorrhages].
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Child; Cyclohexanecarboxylic Acids; Female; He | 1975 |